What Researchers Did
Researchers investigated the therapeutic effects of hyperbaric oxygen therapy (HBO) in 50 patients with chronic occlusive arterial diseases, measuring transcutaneous oxygen pressure, plasma lipid peroxide, and superoxide dismutase levels.
What They Found
Among 30 patients with necrosis or ulceration, 16 (53%) healed and 13 (43%) improved, while 5 of 6 patients (83%) with rest pain experienced relief. All 4 patients with infection were cured, 7 of 8 patients (88%) with delayed amputation wound healing achieved healing, and both patients with bone fractures obtained union. Transcutaneous oxygen pressure significantly increased during and after HBO, but plasma lipid peroxide and superoxide dismutase levels remained unchanged.
What This Means for Canadian Patients
This study suggests that HBO, often combined with other therapies, could be a beneficial treatment option for Canadian patients suffering from chronic occlusive arterial diseases, particularly those with tissue loss, pain, or infection. It may help improve wound healing and reduce pain, potentially preventing amputations or improving recovery from existing ones.
Canadian Relevance
This study has no direct Canadian connection as it was conducted in Japan and does not involve Canadian researchers, institutions, or patient populations.
Study Limitations
A key limitation is the absence of a control group, making it difficult to definitively attribute outcomes solely to hyperbaric oxygen therapy, especially given its combination with other treatments.